Testing effectiveness (Phase 2)Study completedNCT01466153
What this trial is testing
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Who this might be right for
Chronic Lymphocytic Leukemia (CLL)
MedImmune LLC 183